Canopy Growth (CGC) Short-term Investments (2017 - 2025)
Canopy Growth (CGC) reported Short-term Investments of $4.2 million for Q2 2025, down 25.2% on a YoY basis from $5.6 million in Q2 2024, and down 65.82% sequentially from $12.3 million in Q1 2025.
Canopy Growth (CGC) Short-term Investments (2017 - 2025) Analysis & Trends
Canopy Growth (CGC) has 9 years of Short-term Investments data on file, last reported at $4.2 million in Q2 2025.
- For the quarter ending Q2 2025, Short-term Investments fell 25.2% year-over-year to $4.2 million; the trailing twelve-month figure through Jun 2025 stood at $4.2 million (down 25.2% YoY), and the FY2025 full-year result was $12.3 million, up 126.82% from the prior year.
- Short-term Investments declined to $4.2 million in Q2 2025, from $12.3 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $640.9 million in Q4 2021 to a low of $4.2 million in Q2 2025.
- A 5-year average of $147.5 million and a median of $12.0 million in 2024 frame the typical range for Short-term Investments.
- Peak annual rise in Short-term Investments reached 3382.69% in 2021, while the deepest fall reached 98.48% in 2021.
- Tracing CGC's Short-term Investments over 5 years: stood at $640.9 million in 2021, then sank by 78.03% to $140.8 million in 2022, then plunged by 77.34% to $31.9 million in 2023, then sank by 63.13% to $11.8 million in 2024, then tumbled by 64.25% to $4.2 million in 2025.
- Business Quant data shows CGC's Short-term Investments at $4.2 million in Q2 2025, $12.3 million in Q1 2025, and $11.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 12.30 Mn |
| Dec 31, 2024 | 11.76 Mn |
| Sep 30, 2024 | 5.49 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Dec 31, 2023 | 31.91 Mn |
| Sep 30, 2023 | 5.96 Mn |
| Jun 30, 2023 | 6.80 Mn |
| Mar 31, 2023 | 78.06 Mn |
| Dec 31, 2022 | 140.80 Mn |
| Sep 30, 2022 | 304.17 Mn |
| Jun 30, 2022 | 351.09 Mn |
| Mar 31, 2022 | 470.25 Mn |
| Dec 31, 2021 | 640.92 Mn |
| Sep 30, 2021 | 9.71 Mn |
| Jun 30, 2021 | 11.66 Mn |
| Mar 31, 2021 | 559.52 Mn |
| Dec 31, 2020 | 523.59 Mn |
| Sep 30, 2020 | 10.76 Mn |